Abstract:Introduction: Nonketotic hyperglycinemia (NKH) is a rare, life-threatening genetic disorder. The patients usually show heterogeneous and nonspecific symptoms, resulting in diagnosis challenges using conventional approaches. Here, the clinical presentation and genetic features of 20 Chinese patients were examined and reported in order to clarify the natural history and prognosis of NKH in China. Methods: The Human Gene Mutation Database and literature regarding NKH in China were reviewed. Age of onset, clinical characteristics, genetic analysis, cranial magnetic resonance imaging (MRI) and electroencephalography (EEG) examinations, and outcome of the patients were analyzed. Natural history experiences and follow-up assays for five patients who were followed in our center were described. Results: Among all 20 NKH patients, 17 (85%) had the neonatal type and 3 (15%) had the infantile type, no late-onset cases were detected. Patients showed up for admission with a history of seizures (15/20), lethargy (14/20), hypotonia (11/20), apnea (9/20), and feeble sobbing (4/20). Brain MRI findings included abnormal signals in the internal capsule, cerebellum, or brainstem (6/14), dysplasia of the corpus callosum (5/14), and white matter abnormalities (3/14). EEG evaluations showed anomalies such as burst suppression (4/8) and hypsarrhythmia and/or epileptic activity (6/8). Median values of cerebrospinal fluid (CSF) glycine levels, plasma glycine levels and CSF/plasma glycine ratios were135.2 (range, 6.3-546.3) μmol/L, 998.2 (range,75-3,084) μmol/L, 0.16 (range, 0.03-0.60) respectively. Genetic analyses revealed four new variations and GLDC, AMT gene abnormalities in 13 (65%), 7 (35%) case, respectively. Prognosis information was available for 18 cases: nine patients died, eight in the neonatal period. Among the nine survivors, varying developmental disorders were observed. Discussion: Different disease processes and outcomes were found in Chinese NKH patients, according to this study. The initial clinical presentations, CSF glycine levels and CSF to plasma glycine ratios do not reliably predict prognosis, while MRI and EEG abnormalities may indicate a poor outlook. NKH diagnosis should be considered for neonates presenting specific symptoms. The present survey provides clinical data that support the development of a standardized protocol for diagnosing and treating NKH in China.

Two Novel Mutations in the Glycine Decarboxylase Gene in a Boy with Classic Nonketotic Hyperglycinemia: Case Report

[Clinical and Genetic Analyses of a Family with Atypical Nonketotic Hyperglycinemia Caused by Compound Heterozygous Mutations in the GLDC Gene].

Novel GLDC Variants Causing Nonketotic Hyperglycinemia in Chinese Patients

A case of multiple carboxylase deficiency presenting with skin lesions as the initial symptom induced by a novel mutation in the holocarboxylase synthetase gene

Homozygosity for disease-causing variants in AMT and GLDC in a patient with severe nonketotic hyperglycinemia

A Novel Compound Heterozygous Variant of the SLC12A3 Gene in Gitelman Syndrome Pedigree

Case report: Unveiling genetic and phenotypic variability in Nonketotic hyperglycinemia: an atypical early onset case associated with a novel GLRX5 variant

A Novel Nonsense Mutation P.w738x of GAA Gene Identified in a Chinese Patient with Infantile Glycogen Storage Disease Type II

The Mutation Analysis of the AMT Gene in a Chinese Family with Nonketotic Hyperglycinemia

Two Novel CPS1 Mutations in a Case of Carbamoyl Phosphate Synthetase 1 Deficiency Causing Hyperammonemia and Leukodystrophy

The First Pediatric Case of Glucagon Receptor Defect Due to Biallelic Mutations in GCGR is Identified by Newborn Screening of Elevated Arginine

A Novel Composition of Two Heterozygousgfm1mutations in a Chinese Child with Epilepsy and Mental Retardation

Two novel mutations in the CPS 1 gene of a newborn with carbamoyl phosphate synthetase 1 deficiency identified by next-generation sequencing

Phenotypic and genetic analysis of a family with nonketotic hyperglycinemia caused by AMT gene mutation

COG6-CDG: Two Novel Variants and Milder Phenotype in a Chinese Patient

Regulation of glycine metabolism by the glycine cleavage system and conjugation pathway in mouse models of non‐ketotic hyperglycinemia

Clinical and genomic study of the infant with glycogen storage disease typeⅡ

Natural history and outcome of nonketotic hyperglycinemia in China

Clinical and Molecular Investigation in Chinese Patients with Glutaric Aciduria Type I

Clinical and Mutational Spectra of 23 Chinese Patients with Glutaric Aciduria Type 1.

Teaching NeuroImage: Glutaredoxin-5–Associated Variant Nonketotic Hyperglycinemia